Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

HIV drug recommended for prophylaxis

Country: United Kingdom

An established antiviral medicine that has been on the market in Europe since 2005 to treat people with HIV-1 is being recommended for disease prevention as well. Truvada, which contains the active substances emtricitabine and tenofovir disoproxil, has received a positive opinion from the European Medicines Agency for use as pre-exposure prophylaxis, together with safer sex practices.

Read more

CRL for Nicox glaucoma drug

Country: United States

A new drug for glaucoma developed by Nicox SA of France and licensed to a unit of Valeant Pharmaceuticals has been rejected by the US Food and Drug Administration because of deficiencies at the company’s Florida manufacturing plant.

Read more

Celgene invests in Jounce

Country: United States

Read more

Juno acquires RedoxTherapies

Country: United States

Read more

Universal flu vaccine?

Country: Switzerland

Read more

Nextech Invest closes oncology fund

Country: Switzerland

Read more

Storm Therapeutics raises £12 million

Country: United Kingdom

Read more

Roche confirms forecast

Country: Switzerland

Read more

Novartis reports lacklustre second quarter results

Country: Switzerland

Read more

Tiziana acquires Italian biobank

Country: United Kingdom

Read more

Pharming reports positive result for Ruconest

Country: Netherlands

Read more

More evidence for Tagrisso in lung cancer

Country: United Kingdom

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Attacking Zika by modifying mosquitoes, by Karen Finn

ZikaMosquitoesGMKFinnJune2016.pdf

Highlights of the June 2016 MedNous issue

The June 2016 MedNous features:

Latest Mednous cover
  • Research Strategy
    Attacking Zika by modifying mosquitoes
    By Karen Finn
  • Business Strategy
    André Choulika discusses gene editing at Cellectis
  • Oncology Review
    Rising success for oncology drug development
    By Bruno Pagliara
  • Regenerative Medicine
    Cell Medica and Baylor target solid tumours
  • Company Financing
    Allecra raises €22 million for antibiotic
  • Regulation and Policy
    Human trials under scrutiny

The latest MedNous journal. Subscribe to download.